Cite
HARVARD Citation
Hyman, N. et al. (2000). Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. Journal of neurology, neurosurgery and psychiatry. 68 (6), pp. 707-712. [Online].